A growing body of research has revealed a link between the gut microbiome and mental disorders, such as treatment-resistant schizophrenia.
read moreInternational researchers have uncovered potentially diagnostic gut microbiome signatures and metabolic pathways associated specifically with Ulcerative Colitis and Crohn’s disease.
read moreMPR News host Angela Davis revisits a conversation with gastroenterologists, Dr. Alexander Khoruts from the University of Minnesota and Dr. Xiao Jing Wang from Mayo Clinic, who discuss what good gut health looks like and how you can improve your digestive health.
read moreA new study links toxic PFAS “forever chemical” exposure in young adults to reduced gut health, which researchers suspect is a driver of kidney disease later in life.
read moreAnkylosing Spondylitis (AS) is a type of arthritis that causes inflammation in joints and the spine. In a literature review of forty-seven studies, including over 2,000 patients, researchers found that patients with (AS) had significantly reduced lower microbial diversity.
read moreA recent pediatric study investigating the link between sleep and gut health revealed that children with earlier bedtimes had greater microbial diversity, including a higher abundance of certain beneficial bacteria associated with cognitive function.
read moreA study led by researchers in Australia and China researched the impact of healthy gut bacteria and cognitive decline in dementia and Alzheimer's Disease.
read moreIn a recent study, researchers showed that stress-sensitive neural circuits alter the gut microbiome by directly influencing duodenal glands.
read moreA new study in mice concludes that FMT can effectively relieve Type 1 Diabetes associated cognitive decline by reducing the gut–brain metabolic disorders and neuroinflammation, providing a potential therapeutic approach for diabetes-related brain disorders.
read moreFecal microbiota transplantation (FMT), significantly reduced recurrence of hepatic encephalopathy compared with placebo in patients with cirrhosis on standard-of-care treatment, results of a phase 2 randomized controlled trial show.
read more
